Wongkanya, R.; Teeranachaideekul, V.; Makarasen, A.; Chuysinuan, P.; Yingyuad, P.; Nooeaid, P.; Techasakul, S.; Chuenchom, L.; Dechtrirat, D. Electrospun Poly(lactic acid) Nanofiber Mats for Controlled Transdermal Delivery of Essential Oil from Zingiber cassumunar Roxb. Mater. Res. Express, 2020, 7, 055305.

28 Dec 2020
0
0

Wongkanya, R.; Teeranachaideekul, V.; Makarasen, A.; Chuysinuan, P.; Yingyuad, P.; Nooeaid, P.; Techasakul, S.; Chuenchom, L.; Dechtrirat, D. Electrospun Poly(lactic acid) Nanofiber Mats for Controlled Transdermal Delivery of Essential Oil from Zingiber cassumunar Roxb. Mater. Res. Express, 2020, 7, 055305.

Tags

Share this

Related Posts

Nealmongkol, P., Tangdenpaisal, K., Sitthimonchai, S., Ruchirawat, S., & Thasana, N. (2013). Cu(I)-mediated lactone formation in subcritical water: a benign synthesis of benzopyranones and urolithins A–C. Tetrahedron, 69(44), 9277-9283. https://doi.org/10.1016/j.tet.2013.08.045
04 Nov 2013
0

Nealmongkol, P., Tangdenpaisal, K., Sitthimonchai, S., Ruchirawat, S., & Thasana, N. (2013). Cu(I)-mediated lactone formation in subcritical water: a benign synthesis of benzopyranones and urolithins A–C. Tetrahedron, 69(44), 9277-9283. https://doi.org/10.1016/j.tet.2013.08.045

Nealmongkol, P., Tangdenpaisal, K., Sitthimonchai, S., Ruchirawat, S., & Thasana, N. (2013). Cu(I)-mediated lactone formation in subcritical water: a benign synthesis of benzopyranones and urolithins A–C. Tetrahedron, 69(44), 9277-9283. https://doi.org/10.1016/j.tet.2013.08.045
View More

Recent Posts

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)
New
20 Sep 2023
0
New

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial) Siripongboonsitti T, Ungtrakul T, Tawinprai K, Auewarakul C, Chartisathian W, Jansala T, Julsawad R, Soonklang K, Mahanonda N, Mahidol C Phytomedicine. 2023;119:155018.
View More